References
- Gardner RC, Yaffe K. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci. 2015;66(Pt B):75–80. doi:10.1016/j.mcn.2015.03.001.
- Korley FK, Kelen GD, Jones CM, Diaz-Arrastia R. Emergency department evaluation of traumatic brain injury in the United States, 2009–2010. J Head Trauma Rehabil. 2016;31(6):379–87. doi:10.1097/HTR.0000000000000187.
- Sierzenski PR, Linton OW, Jr ES Amis, Courtney DM, Larson PA, Mahesh M, Novelline RA, Frush DP, Mettler FATimins JK. Tenforde ts. Applications Of Justification and Optimization in Medical Imaging: Examples Of Clinical Guidance for Computed Tomography Use in Emergency Medicine. Annals Of Emergency Medicine. 2014 Jan 1;63:25–32.
- Tuttolomondo A, Pecoraro R, Pinto A. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Des Devel Ther. 2014;8:2221–38. doi:10.2147/DDDT.
- Werhane ML, Evangelista ND, Clark AL, Sorg SF, Bangen KJ, Tran M, Schiehser DM, Delano-Wood L. Pathological vascular and inflammatory biomarkers of acute- and chronic-phase traumatic brain injury. Concussion (London, England). 2017;2:Cnc30.
- North SH, Shriver-Lake LC, Taitt CR, Ligler FS. Rapid analytical methods for on-site triage for traumatic brain injury. Annu Rev Anal Chem (Palo Alto, Calif). 2012;5:35–56. doi:10.1146/annurev-anchem-062011-143105.
- Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, Hoh BL, Blackburn S, Doré S. Role of interleukin-10 in acute brain injuries. Front Neurol. 2017;8:244.
- Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, Mouri T, Tajima G, Kajino K, Nakae H, Tanaka H, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock (Augusta, Ga). 2005;23(5):406–10. doi:10.1097/01.shk.0000161385.62758.24.
- Lagerstedt L, Egea-Guerrero JJ, Rodríguez-Rodríguez A, Bustamante A, Montaner J, El Rahal A, Andereggen E, Rinaldi L, Sarrafzadeh A, Schaller K, et al. Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury. PLoS One. 2018;13(2):e0193278. doi:10.1371/journal.pone.0193278.